Our Capabilities: Clinical Development, Market Access & Regulatory Consultants  

As your trusted regulatory partner, Cisema provides strategic and operational expertise to accelerate the successful commercialization of life sciences products and other regulated goods across China and the broader Asia Pacific region.

With over 20 years of in-market experience, we support clients throughout the product lifecycle, from clinical development and regulatory strategy to market authorization, quality system compliance, post-market surveillance, sourcing, and pre-shipment inspection.

With over 20 years of in-market experience, we support clients throughout the product lifecycle, from clinical development and regulatory strategy to market authorization, quality system compliance, post-market surveillance, sourcing, and pre-shipment inspection.

We facilitate effective engagement with competent authorities and ensure seamless navigation of local regulatory challenges. This empowers our clients to achieve timely market entry, sustain compliance, and address regulatory complexity in dynamic environments.

Two men in business suits sitting at a table engaged in a meeting with a third person.
Scientist wearing safety goggles and blue gloves examining a sample under a microscope in a laboratory.
Regulatory affairs expertise

Clinical Development Services 

Commercialization & Certification Strategy for Life Sciences & Regulated Goods

We combine regulatory intelligence with commercial acumen to help companies secure market access across Asia Pacific. Our consultants develop tailored strategies that align with local pricing, reimbursement, and procurement frameworks, while supporting global commercialization objectives.

Key solutions include: 

Market access pathways for pharmaceuticals including National Reimbursement Drug List, Provincial Reimbursement Drug List, and Health Technology Assessments
Access strategies for medical devices, IVDs, supplements, and food for special medical purposes (FSMPs)
Certification and regulatory compliance support for cosmetics, ingredients, and health food
Stakeholder engagement, health economic modeling, and market positioning
Clinical development planning and regulatory strategies
Regulatory and clinical gap assessments
Support for breakthrough and accelerated approval pathways
Regulatory authority engagement and submission management

We deploy technology-enabled platforms, centralized monitoring, and risk-based methodologies to improve regulatory compliance, streamline clinical operations, and ensure data integrity throughout the product lifecycle.

Discover more

Market Access Consulting

Integrated Clinical & Regulatory Services for Life Sciences

Cisema provides clinical development services tailored to the regulatory landscapes of China and the broader Asia Pacific region. Leveraging over two decades of regional expertise, we support companies across the life sciences spectrum. Including pharma, biotech, medical devices, IVDs, health food, food for special medical purposes (FSMPs), supplements, and veterinary products through every phase of development and commercialization.

Our core solutions include: 

Clinical trial execution in China for medical devices and IVDs
Scientific and medical writing including Clinical Evaluation Reports (CERs) and Performance Evaluation Reports (PERs)
Market access and commercialization strategy development
Post-market surveillance and real-world evidence generation
Regulatory consulting for industrial and consumer goods, including:
  • China Compulsory Certification (CCC) 
  • China Energy Label (CEL) 
  • State Radio Regulation of China Certifications (SRRC) 
  • China Manufacturing License (CML) from the Special Equipment Licensing Office (SELO) amongst others 

We help you navigate local regulatory and commercial requirements while maintaining alignment with global standards and strategic goals. 

Discover more

Regulatory Affairs Consulting 

Submission Strategy & Product Registration Across Sectors

Our team of regulatory affairs consultants provide strategic guidance and hands-on support to navigate product classification, registration, and lifecycle compliance. We advise across life sciences, health food, cosmetics, veterinary products, and regulated industrial and consumer goods.

Key solutions include:

Regulatory strategy, planning and submission support for pharma, including:
  • (Pre-) Investigational New Drug applications (INDs) 
  • Clinical Trial Applications (CTAs)  
  • (Pre-) New Drug Applications (NDAs) 
  • Marketing Authorization Applications (MAAs) 
  • Biologics License Applications (BLAs) 
  • Drug Master Files (DMFs) 
Product classification and technical dossier preparation 
Engagement with regulatory agencies such as the National Medical Products Administration (NMPA) (China), the Taiwan Food and Drug Administration (TFDA), the Health Sciences Authority (Singapore) (HSA), and major markets of the Association of Southeast Asian Nations (ASEAN) 
Registration and approvals for cosmetics, health foods, FSMPs, and veterinary products 
Regulatory submissions for CCC, CEL, SELO/CML, Network Access License (NAL), and other regulated industrial and consumer goods

Our deep understanding of and frequent communication with regulatory authorities enables us to anticipate challenges, support inspection readiness, and ensure long-term compliance across diverse regulatory environments.

Discover more

Quality Management & Compliance 

GxP Systems & Regulatory Compliance for Market Readiness

We support the design, implementation, and maintenance of quality management systems that meet both international standards and country-specific regulatory requirements. Our compliance consultants are industry experts in their respective domains: life sciences, food, cosmetics, and industrial sectors.

Key solutions include:

GMP and labeling compliance for health foods and FSMPs under the State Administration for Market Regulation (SAMR) 
Quality compliance for CCC, SELO and other regulated consumer products 
Supplier audits, SOP development and inspection readiness
GxP systems design and readiness for pharmaceutical operations
ISO 13485 and China GMP adaptation for medical devices and IVDs
ISO 22716 and CSAR-aligned systems for cosmetics

We align global quality frameworks with local implementation standards to ensure regulatory compliance and operational excellence. We provide guidance and support to clients on how to design quality systems that enhance efficiencies, reduce costs, and improve business effectiveness. By integrating technology, data-driven oversight, and scientific methodologies, we ensure seamless implementation and continuous improvement in compliance and quality management.

Discover more

Pharmacovigilance & Post-Market Surveillance 

Safety Monitoring & Lifecycle Compliance 

We establish and manage post-market systems to meet pharmacovigilance and surveillance obligations across product categories and jurisdictions. 

Key solutions include:

Cosmetovigilance programs aligned with China’s Cosmetic Supervision and Administration Regulation (CSAR) and Taiwan’s FDA requirements 
Post-market safety monitoring for health foods, food for special medical purposes (FSMPs), and veterinary products 
Lifecycle safety reviews, corrective action planning, and global compliance coordination
Pharmacovigilance systems, Qualified Person Responsible for Pharmacovigilance (QPPV) services, Periodic Safety Update Report (PSUR) or Development Safety Update Report (DSUR) support 
Device vigilance and Post Market Surveillance in China, Hong Kong, Macau, Taiwan, and ASEAN 
Discover more

Sourcing Agent Services 

Regulatory-Compliant Sourcing across Asia Pacific 

We act as your strategic sourcing partner across China and Southeast Asia to ensure products meet all regulatory compliance and quality requirements prior to market entry. 

Key solutions include:

Labeling, documentation and regulatory compliance verification 
Cost-effective procurement with integrated regulatory oversight 
Supply chain transparency and traceability 
Supplier identification and regulatory due diligence 
Sourcing for products requiring CCC, CEL, SRRC, SELO, certifications and more 

Our local presence and deep expertise in APAC supply markets ensure sourcing strategies align with both regulatory obligations and business objectives. 

Discover more

Quality Control Pre-Shipment Inspection Services

End-of-Line Regulatory Checks for Export-Ready Products 

We conduct detailed inspections to ensure your shipments meet compliance, safety, and contractual specifications before export. 

Inspection types include: 

First Article Inspection (FAI) for initial production validation 
In-Process Inspection (IPI) during critical production stages 
Pre-Shipment Inspection (PSI) for final quality and conformity checks 
On-Arrival Inspection and container loading supervision 
Verification of certificates of conformity, labeling, packaging, and export documentation

Our experts help safeguard regulatory compliance and protect market access through rigorous end-of-line quality assurance. 

Discover more
Industry and technical expertise

Why Work with Cisema?

One Partner, Full Lifecycle Support

From pre-market strategy to post-market compliance, we provide support to internal regulatory teams and ensure seamless lifecycle management.

Regional Reach, Global Presence

Based in Asia and Europe with a global team delivering global reach.

Cross-Industry Expertise

Pharma, biotech, medical devices, cosmetics, supplements, veterinary, industrial and consumer goods.

Proven Results

Over 20 years of regulatory submissions, regulatory expertise, and approvals to drive business success.

Why Work with Cisema

Contact Our Consultants & Discover How We Can Support You

Let Cisema help turn your plans into reality.

Request Proposal